Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis

International Journal of Cardiology

Volumn 231, Issue , 2017, Pages 216-221

  Ammirati, Enrico ^a   Moroni, Francesco ^b   Sormani, Paola ^a,c   Peritore, Angelica ^a   Milazzo, Angela ^a   Quattrocchi, Giuseppina ^a   Cipriani, Manlio ^a   Oliva, Fabrizio ^a   Giannattasio, Cristina ^a,c   Frigerio, Maria ^a   Roghi, Alberto ^a   Camici, Paolo G ^b   Pedrotti, Patrizia ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Acute myocarditis; Cardiac magnetic resonance; Fulminant myocarditis; Late gadolinium enhancement

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; GADOLINIUM; TROPONIN; CONTRAST MEDIUM; GADOBUTROL; ORGANOMETALLIC COMPOUND;

ACUTE MYOCARDITIS; ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CONTRAST ENHANCEMENT; CORRELATIONAL STUDY; DYSPNEA; FAINTNESS; FEMALE; HEART ARREST; HEART EDEMA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR MASS INDEX; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; THORAX PAIN; ACUTE DISEASE; CARDIAC MUSCLE; CINE MAGNETIC RESONANCE IMAGING; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; TIME FACTOR;

ACUTE DISEASE; ADULT; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDITIS; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 85007476980     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.11.282     Document Type: Article

References (25)

1. [1] Biesbroek, P.S., Beek, A.M., Germans, T., Niessen, H.W., van Rossum, A.C., Diagnosis of myocarditis: current state and future perspectives. Int. J. Cardiol. 191 (2015), 211–219.
2. [2] Sagar, S., Liu, P.P., Cooper, L.T. Jr., Myocarditis. Lancet 379 (2012), 738–747.
3. [3] Ginsberg, F., Parrillo, J.E., Fulminant myocarditis. Crit. Care Clin. 29 (2013), 465–483.
4. [4] Kindermann, I., Barth, C., Mahfoud, F., Ukena, C., Lenski, M., Yilmaz, A., et al. Update on myocarditis. J. Am. Coll. Cardiol. 59 (2012), 779–792.
5. [5] Friedrich, M.G., Sechtem, U., Schulz-Menger, J., Holmvang, G., Alakija, P., Cooper, L.T., et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J. Am. Coll. Cardiol. 53 (2009), 1475–1487.
6. [6] Caforio, A.L., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S.B., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur. Heart J. 34 (2013), 2636–2648 (48a-48d).
7. [7] Grun, S., Schumm, J., Greulich, S., Wagner, A., Schneider, S., Bruder, O., et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J. Am. Coll. Cardiol. 59 (2012), 1604–1615.
8. [8] Chopra, H., Arangalage, D., Bouleti, C., Zarka, S., Fayard, F., Chillon, S., et al. Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. Int. J. Cardiol. 212 (2016), 63–69.
9. [9] Agoston-Coldea, L., Kouaho, S., Sacre, K., Dossier, A., Escoubet, B., Chillon, S., et al. High mass (> 18 g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis. Int. J. Cardiol. 222 (2016), 950–956.
10. [10] Luetkens, J.A., Homsi, R., Dabir, D., Kuetting, D.L., Marx, C., Doerner, J., et al. Comprehensive cardiac magnetic resonance for short-term follow-up in acute myocarditis. J. Am. Heart Assoc., 5, 2016.
11. [11] Vermes, E., Childs, H., Faris, P., Friedrich, M.G., Predictive value of CMR criteria for LV functional improvement in patients with acute myocarditis. Eur. Heart J. Cardiovasc. Imaging 15 (2014), 1140–1144.
12. [12] Mavrogeni, S., Spargias, C., Bratis, C., Kolovou, G., Markussis, V., Papadopoulou, E., et al. Myocarditis as a precipitating factor for heart failure: evaluation and 1-year follow-up using cardiovascular magnetic resonance and endomyocardial biopsy. Eur. J. Heart Fail. 13 (2011), 830–837.
13. [13] Zagrosek, A., Abdel-Aty, H., Boye, P., Wassmuth, R., Messroghli, D., Utz, W., et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc. Imaging 2 (2009), 131–138.
14. [14] Cooper, L.T., Baughman, K.L., Feldman, A.M., Frustaci, A., Jessup, M., Kuhl, U., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J. Am. Coll. Cardiol. 50 (2007), 1914–1931.
15. [15] Kramer, C.M., Barkhausen, J., Flamm, S.D., Kim, R.J., Nagel, E., Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized P, Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J. Cardiovasc. Magn. Reson., 10, 2008, 35.
16. [16] Kramer, C.M., Barkhausen, J., Flamm, S.D., Kim, R.J., Nagel, E., Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized P. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J. Cardiovasc. Magn. Reson., 15, 2013, 91.
17. [17] Simonetti, O.P., Finn, J.P., White, R.D., Laub, G., Henry, D.A., “Black blood” T2-weighted inversion-recovery MR imaging of the heart. Radiology 199 (1996), 49–57.
18. [18] Schulz-Menger, J., Bluemke, D.A., Bremerich, J., Flamm, S.D., Fogel, M.A., Friedrich, M.G., et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J. Cardiovasc. Magn. Reson., 15, 2013, 35.
19. [19] Bondarenko, O., Beek, A.M., Hofman, M.B., Kuhl, H.P., Twisk, J.W., van Dockum, W.G., et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J. Cardiovasc. Magn. Reson. 7 (2005), 481–485.
20. [20] Gao, P., Yee, R., Gula, L., Krahn, A.D., Skanes, A., Leong-Sit, P., et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ. Cardiovasc. Imaging 5 (2012), 448–456.
21. [21] Ibrahim, T., Hackl, T., Nekolla, S.G., Breuer, M., Feldmair, M., Schomig, A., et al. Acute myocardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Radiology 254 (2010), 88–97.
22. [22] Luetkens, J.A., Homsi, R., Sprinkart, A.M., Doerner, J., Dabir, D., Kuetting, D.L., et al. Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur. Heart J. Cardiovasc. Imaging 17 (2016), 154–161.
23. [23] Wagner, A., Schulz-Menger, J., Dietz, R., Friedrich, M.G., Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. MAGMA 16 (2003), 17–20.
24. [24] Ferreira, V.M., Piechnik, S.K., Dall'Armellina, E., Karamitsos, T.D., Francis, J.M., Ntusi, N., et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc. Imaging 6 (2013), 1048–1058.
25. [25] Schelbert, E.B., Messroghli, D.R., State of the art: clinical applications of cardiac T1 mapping. Radiology 278 (2016), 658–676.